Implementation of HR 4993 the Joe Fiandra Access to Home Infusion Act, including issues in CMS-1828-P; Promoting US competitiveness while ensuring continued patient access to lifesaving medicines
Literal federal measure citations: HR 4993
2026 · 3rd Quarter (July 1 - Sep 30)
CHIESI USA, INC.
Filed by SPLITOAK STRATEGIES LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 21, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- SPLITOAK STRATEGIES LLC
- Client
- CHIESI USA, INC.
- Filing UUID
- 4e415b36-c629-435e-a9e8-731d2e3d6f4c
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Preserving US competitiveness and patient access to lifesaving medicines, especially for treatment of rare diseases; Childhood genetic screening access
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.